These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 8569232

  • 1. Acute hemodynamic effects of ciprokiren, a novel renin inhibitor, in sodium-depleted dogs.
    Clozel JP, Véniant M, Sprecher U, Fischli W.
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):674-7. PubMed ID: 8569232
    [Abstract] [Full Text] [Related]

  • 2. Ciprokiren (Ro 44-9375). A renin inhibitor with increasing effects on chronic treatment.
    Fischli W, Clozel JP, Breu V, Buchmann S, Mathews S, Stadler H, Vieira E, Wostl W.
    Hypertension; 1994 Aug; 24(2):163-9. PubMed ID: 8039839
    [Abstract] [Full Text] [Related]

  • 3. Effects of renin inhibitor A-72517 on hemodynamics and cardiac function in sodium-depleted dogs.
    Wessale JL, Kleinert HD, Calzadilla SV, Kovar PJ, Rosenberg SH.
    Am J Hypertens; 1993 Jun; 6(6 Pt 1):514-21. PubMed ID: 8343235
    [Abstract] [Full Text] [Related]

  • 4. Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure.
    Barbe F, Su JB, Guyene TT, Crozatier B, Ménard J, Hittinger L.
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H1985-92. PubMed ID: 8764248
    [Abstract] [Full Text] [Related]

  • 5. Renal vascular and biochemical responses to systemic renin inhibition in dogs at low renal perfusion pressure.
    Clozel JP, Véniant MM, Qiu C, Sprecher U, Wolfgang R, Fischli W.
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):674-82. PubMed ID: 10547083
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects and hemodynamic mechanism of action of the novel, nonpeptidic renin inhibitor A-74273 in dogs.
    Wessale JL, Calzadilla SV, Boyd SA, Baker WR, Stein HH, Kovar PJ, Barlow J, Klinghofer V, Mantei R, Kleinert HD.
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):644-52. PubMed ID: 7505369
    [Abstract] [Full Text] [Related]

  • 7. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Su J, Barbe F, Houël R, Guyene TT, Crozatier B, Hittinger L.
    Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
    [Abstract] [Full Text] [Related]

  • 8. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
    van Kats JP, Sassen LM, Danser AH, Polak MP, Soei LK, Derkx FH, Schalekamp MA, Verdouw PD.
    Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
    Sweet CS, Ludden CT, Frederick CM, Ribeiro LG.
    Am J Med; 1984 Aug 20; 77(2A):7-12. PubMed ID: 6089558
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs.
    Clozel JP, Hess P, Schietinger K, Breu V, Fischli W, Baumgartner HR.
    Life Sci; 1994 Aug 20; 54(6):PL87-92. PubMed ID: 8295484
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
    Liang CS, Gavras H, Hood WB.
    J Clin Invest; 1978 Apr 20; 61(4):874-83. PubMed ID: 659580
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
    Sweet CS, Ludden CT, Frederick CM, Bush LR, Ribeiro LG.
    J Cardiovasc Pharmacol; 1984 Apr 20; 6(6):1067-75. PubMed ID: 6084762
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs.
    Holck M, Fischli W, Hefti F, Gerold M.
    J Cardiovasc Pharmacol; 1986 Apr 20; 8(1):99-108. PubMed ID: 2419701
    [Abstract] [Full Text] [Related]

  • 18. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W, Linder L, Kleinbloesem C, van Brummelen P, Bühler FR.
    Circulation; 1992 Jan 20; 85(1):1-8. PubMed ID: 1728438
    [Abstract] [Full Text] [Related]

  • 19. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
    Kiowski W, Beermann J, Rickenbacher P, Haemmerli R, Thomas M, Burkart F, Meinertz T.
    Circulation; 1994 Dec 20; 90(6):2748-56. PubMed ID: 7994817
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.